Skip to content

Clinical study of acupoint embedding to alleviate insulin resistance in children and adolescents with gastric heat-dampness obesity

Clinical study of acupoint embedding to alleviate insulin resistance in children and adolescents with gastric heat-dampness obesity

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000405
Enrollment
Unknown
Registered
2025-02-25
Start date
2023-03-25
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

obesity

Interventions

control group:nutrition intervention

Sponsors

Childrens Hospital Zhejiang University School of Medicine National Clinical Research Center for Child Health
Lead Sponsor

Eligibility

Sex/Gender
All
Age
7 Years to 18 Years

Inclusion criteria

Inclusion criteria: Diagnostic criteria 1) Western diagnostic criteria:The Z-score (BAZ) of age-specific BMI was used as the basis and the exact value was calculated by WHO Anthro Plus (www.who.int/en/).Obesity: BAZ > 2. 2) TCM syndrome differentiation criteria:According to the standards of the fifth National Academic Conference on Obesity Research in 1997 the type of stomach heat and dampness: obesity head distension vertigo depletion of grain and good hunger limb weight sleepy Chu laziness thirst drinking pulse slip tongue coating greasy yellow tongue red.If there are more than 2 to 3 diagnostic syndroms and the tongue and pulse are basically consistent it can be diagnosed as this type. Inclusion criteria: 1) Those who meet the above diagnostic criteria of Western medicine and TCM syndrome diagnosis criteria; 2) Age between 7-18 years old male or female; 3)Children and their families were informed and willing to be tested signed informed consent agreed to participate in the study and comply with the study protocol.

Exclusion criteria

Exclusion criteria: 1) Secondary obesity caused by endocrine and metabolic diseases; (2) Patients with serious heart, brain, liver, kidney and other important organs and blood system lesions; (3) Skin and subcutaneous tissue absorption and repair dysfunction; 4) Patients who have taken diet drugs or hypoglycemic drugs in the past 3 months; (5) Have a mental illness, can not cooperate with the treatment or curative effect observer;

Design outcomes

Primary

MeasureTime frame
BMI Z-score;

Secondary

MeasureTime frame
BMI;waist circumference;HOMA-IR;Comprehensive efficacy rating;VFA;FMP;

Countries

China

Contacts

Public ContactDong Haicheng

Childrens Hospital Zhejiang University School of Medicine National Clinical Research Center for Child Health

dhc_1226@126.com15068865010

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026